Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · IEX Real-Time Price · USD
3.420
-0.050 (-1.44%)
Jul 19, 2024, 4:00 PM EDT - Market closed
RGC Market Cap
RGC has a market cap or net worth of $44.50 million as of July 22, 2024. Its market cap has decreased by -85.16% in one year.
Market Cap
44.50M
Enterprise Value
33.40M
1-Year Change
-85.16%
Ranking
Category
Stock Price
$3.42
Market Cap Chart
Since the IPO on July 16, 2021, RGC's market cap has decreased from $120.10M to $44.50M, a decrease of -62.94%. That is a compound annual growth rate of -28.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 44.50M | -67.42% |
| Dec 29, 2023 | 136.60M | -62.36% |
| Dec 30, 2022 | 362.90M | -9.88% |
| Dec 31, 2021 | 402.70M | 235.30% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Daxor | 45.85M |
| Carisma Therapeutics | 45.70M |
| Marker Therapeutics | 45.00M |
| Matinas BioPharma Holdings | 44.97M |
| Lucid Diagnostics | 44.71M |
| CalciMedica | 44.40M |
| Qilian International Holding Group | 44.26M |
| BioXcel Therapeutics | 43.91M |